Target intelligence / Profile preview

Renal oxidative stress pathways and antioxidant enzyme systems

Molecular classification
Enzyme, Transcription factor, Signaling pathway
01

Overview

Renal oxidative stress pathways and antioxidant enzyme systems encompass the integrated network of molecules responsible for maintaining redox balance within the kidney. This system includes primary antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, which neutralize reactive oxygen species (ROS) like superoxide and hydrogen peroxide (PMID: 24508240). The Nuclear factor erythroid 2-related factor 2 (Nrf2) serves as a master transcriptional regulator, coordinating the expression of these enzymes in response to oxidative challenge (PMID: 30107163). In pathological states like chronic kidney disease (CKD) and diabetic nephropathy, an overproduction of ROS from sources like NADPH oxidase (NOX) overwhelms these defenses. This imbalance leads to lipid peroxidation, DNA damage, and protein carbonylation, which are hallmarks of renal injury. Such oxidative damage triggers downstream inflammatory and fibrotic cascades that accelerate the decline of the glomerular filtration rate. Pharmacological interventions, such as Nrf2 activators (e.g., Bardoxolone methyl) or ROS scavengers, aim to restore this balance to protect renal architecture (PMID: 28438337). However, targeting these pathways is complex, as ROS also serve as essential signaling molecules in normal physiological processes.

Other names
Renal antioxidant defense systemKidney redox signaling pathwaysRenal oxidative stress markers
02

Mechanism of action

Activation of the Nrf2 signaling pathway to induce antioxidant gene expression, direct scavenging of reactive oxygen species, and inhibition of pro-oxidant enzymes like NADPH oxidase.

03

Biological functions

Redox homeostasisCellular protectionDetoxificationSignal transduction
04

Disease associations

Chronic kidney diseaseAcute kidney injuryDiabetic nephropathyHypertensionPolycystic kidney disease
05

Safety considerations

Potential for cardiovascular adverse events (e.g., fluid retention with Nrf2 activators)Interference with physiological ROS signalingAntioxidant paradox where high doses may become pro-oxidant
06

Interacting drugs

Bardoxolone methyl

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione (GSH) levelsSuperoxide dismutase (SOD) activity

Beyond the preview

Go deeper on Renal oxidative stress pathways and antioxidant enzyme systems.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal oxidative stress pathways and antioxidant enzyme systems.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call